ÂÜÀòÂÒÂ×

Tanel helps manage the UCL Technology Fund, which is investing in commercialisation of life and physical science innovations from one of the most important academic institutions in the United Kingdom. He joined Albion in 2018 having previously been an intern with the investment team in 2016. Tanel completed his PhD and postdoctoral research at UCL where his work was focused on developing synthetic biological tools for microbiome engineering. He also holds an MSc in Nanotechnology and Regenerative Medicine from UCL and a BSc in Human Biology from King’s College London.